Policy & Regulation
Mundipharma's laboratory testing confirms BETADINE effectiveness against SARS-CoV-2
10 July 2020 -

Mundipharma, a global pharma network, has announced that laboratory testing at the Duke-NUS Medical School in Singapore confirmed the effectiveness of its BETADINE antiseptic products against the SARS-CoV-2 that causes COVID-19 disease, it was reported on Thursday.

Testing indicated that the product's in-vitro virucidal activity kills 99.99% of the virus in 30 seconds.

Another Laboratory testing completed at the Tropical Infectious Diseases Research and Education Center at the University of Malaya, Malaysia, also indicated strong in-vitro virucidal activity, with the tested product BETADINE Gargle and Mouthwash (1.0-% PVP-I) killing 99.99% of the SARS-CoV-2 virus in 15 seconds. The BETADINE antiseptic range includes Povidone-iodine.

Login
Username:

Password: